Profile data is unavailable for this security.
About the company
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
- Revenue in USD (TTM)2.96m
- Net income in USD-291.86m
- Incorporated2010
- Employees183.00
- LocationCibus Inc6455 Nancy Ridge DriveSAN DIEGO 92121United StatesUSA
- Phone+1 (858) 450-0008
- Fax+1 (302) 636-5454
- Websitehttps://calyxt.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DIH Holding US Inc | 67.62m | -6.14m | 84.74m | 192.00 | -- | -- | -- | 1.25 | -0.1903 | -0.1903 | 1.96 | -0.9841 | 1.99 | 4.12 | 11.80 | 352,161.50 | -18.09 | -- | -- | -- | 48.86 | -- | -9.09 | -- | 0.4221 | -3.38 | -- | -- | 19.26 | -- | -732.64 | -- | -- | -- |
| Pro-Dex Inc | 53.84m | 2.13m | 89.69m | 148.00 | 43.94 | 2.91 | 27.29 | 1.67 | 0.6079 | 0.6079 | 15.21 | 9.18 | 1.03 | 2.50 | 4.52 | 363,810.80 | 4.08 | 12.33 | 5.20 | 15.30 | 27.02 | 31.26 | 3.95 | 12.13 | 1.66 | 1.58 | 0.2784 | 0.00 | 16.83 | 14.66 | -69.93 | -12.47 | -6.80 | -- |
| Monogram Technologies Inc | 365.00k | -11.69m | 90.03m | 28.00 | -- | 12.77 | -- | 246.67 | -0.3745 | -0.3745 | 0.0118 | 0.2224 | 0.0239 | -- | -- | 13,035.71 | -76.61 | -119.26 | -117.14 | -257.40 | 0.00 | -- | -3,203.87 | -5,045.60 | -- | -- | 0.00 | -- | -- | -- | -0.3964 | -- | -15.97 | -- |
| Sensus Healthcare Inc | 36.37m | 6.65m | 95.06m | 35.00 | 14.25 | 1.80 | 13.85 | 2.61 | 0.4072 | 0.4072 | 2.23 | 3.23 | 0.6601 | 1.10 | 2.65 | 1,039,057.00 | 12.06 | 10.29 | 13.25 | 12.14 | 60.23 | 62.85 | 18.27 | 15.29 | 8.20 | -- | 0.00 | -- | -45.20 | -1.58 | -98.00 | -- | -23.16 | -- |
| Xtant Medical Holdings Inc | 110.94m | -3.33m | 97.44m | 207.00 | -- | 2.03 | 170.36 | 0.8783 | -0.0284 | -0.0284 | 0.8431 | 0.3454 | 1.38 | 1.40 | 6.35 | 535,956.50 | -4.15 | -10.38 | -5.77 | -14.68 | 61.61 | 61.08 | -3.00 | -8.66 | 1.01 | -4.54 | 0.429 | -- | 57.50 | 4.81 | 107.78 | -- | 18.47 | -- |
| Edap Tms SA (ADR) | 69.26m | -21.95m | 113.18m | 307.00 | -- | 2.13 | -- | 1.63 | -0.592 | -0.592 | 1.87 | 1.43 | 0.6992 | 2.37 | 3.42 | 225,598.80 | -22.16 | -6.62 | -31.50 | -9.22 | 40.34 | 43.23 | -31.69 | -9.59 | 1.80 | -- | 0.0599 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Cibus Inc | 2.96m | -291.86m | 116.51m | 183.00 | -- | 0.3403 | -- | 39.35 | -16.39 | -16.39 | 0.1545 | 11.75 | 0.0043 | -- | 3.09 | 16,180.33 | -53.70 | -86.28 | -64.26 | -96.45 | -- | -- | -12,400.74 | -792.07 | -- | -2.66 | 0.0032 | -- | 1,057.33 | 50.41 | -1,484.44 | -- | 18.53 | -- |
| Myomo Inc | 21.11m | -9.45m | 117.58m | 101.00 | -- | 12.14 | -- | 5.57 | -0.2614 | -0.2614 | 0.5833 | 0.3204 | 1.43 | 3.50 | 10.13 | 209,020.40 | -64.07 | -81.78 | -101.11 | -115.27 | 67.35 | 68.50 | -44.75 | -85.76 | 1.94 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Fonar Corp | 102.72m | 10.29m | 117.77m | 561.00 | 11.85 | 0.7106 | 6.24 | 1.15 | 1.48 | 1.48 | 14.72 | 24.70 | 0.5023 | 19.99 | 1.41 | 183,098.20 | 7.16 | 8.73 | 7.40 | 9.60 | 45.55 | 48.33 | 14.26 | 16.39 | 9.16 | -- | 0.0051 | -- | 1.08 | 3.89 | -24.71 | -15.05 | 8.48 | -- |
| Harvard Bioscience, Inc. | 101.13m | -10.68m | 119.93m | 391.00 | -- | 1.78 | -- | 1.19 | -0.2471 | -0.2471 | 2.35 | 1.54 | 0.7441 | 1.64 | 6.88 | 258,631.70 | -7.86 | -3.29 | -9.44 | -3.89 | 58.39 | 56.67 | -10.56 | -4.57 | 0.9416 | -1.31 | 0.3467 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| KORU Medical Systems Inc | 30.82m | -11.76m | 123.35m | 82.00 | -- | 6.59 | -- | 4.00 | -0.2574 | -0.2574 | 0.6742 | 0.4082 | 0.9737 | 2.94 | 6.50 | 375,817.30 | -37.15 | -17.60 | -43.48 | -20.29 | 62.49 | 59.44 | -38.16 | -21.70 | 3.27 | -- | 0.0195 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| EUDA Health Holdings Ltd | 3.71m | -8.44m | 126.46m | 106.00 | -- | -- | -- | 34.12 | -0.3685 | -0.4384 | 0.1707 | -0.3045 | 0.2752 | -- | 3.55 | 34,966.61 | -62.62 | -- | -- | -- | 22.72 | -- | -227.57 | -- | -- | -1.49 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| 908 Devices Inc. | 52.69m | -37.99m | 127.54m | 230.00 | -- | 0.8151 | -- | 2.42 | -1.15 | -1.15 | 1.60 | 4.52 | 0.2511 | 1.54 | 4.95 | 229,069.60 | -18.11 | -14.16 | -20.12 | -15.35 | 52.32 | 53.02 | -72.10 | -64.25 | 4.23 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| InfuSystem Holdings Inc | 129.37m | 366.00k | 137.70m | 499.00 | 412.52 | 2.57 | 10.99 | 1.06 | 0.0157 | 0.0157 | 5.99 | 2.51 | 1.22 | 10.38 | 6.44 | 259,264.50 | 0.3465 | 4.60 | 0.401 | 5.69 | 49.68 | 56.43 | 0.2829 | 4.07 | 1.64 | 1.97 | 0.3898 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Akoya Biosciences Inc | 93.22m | -60.35m | 142.56m | 330.00 | -- | 6.40 | -- | 1.53 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Cibus Inc's reporting currency: US Dollar USD
25.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 2.80m | 12.24% |
| Vantage Consulting Group, Inc.as of 31 Mar 2024 | 1.14m | 5.01% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 716.64k | 3.14% |
| Geode Capital Management LLCas of 30 Jun 2024 | 376.04k | 1.65% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 216.00k | 0.95% |
| Corient Private Wealth LLCas of 31 Mar 2024 | 121.72k | 0.53% |
| Glenview Capital Management LLCas of 31 Mar 2024 | 116.47k | 0.51% |
| Millennium Management LLCas of 31 Mar 2024 | 96.69k | 0.42% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 95.89k | 0.42% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 56.39k | 0.25% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
